Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...
The Senate is gearing up for another week of controversial confirmation hearings, including Tulsi Gabbard for director of national intelligence, Kash Patel for director of the FBI and RFK, Jr. for HHS ...